The RSC-BMCS (Biological and Medicinal Chemistry Sector) will host its eleventh postgraduate symposium for PhD students and post-doctoral workers researching in biological or medicinal chemistry and related areas. Researchers working in these areas are invited to participate.
Registration will open at 9 am, and talks will start at 10 am.
The day will consist of 11 oral presentations (8 students, 3 keynotes) plus a flash poster section. Each 20-minute student talk will be followed by 10 minutes for questions. Throughout the day, there will be keynote talks from industrial and academic chemists. A buffet lunch will be provided to accompany the poster session.
Confirmed guest speakers are:
Sarah Major, Evotec
Youcef Mehellou, Cardiff University
William McCoull, AstraZeneca
Registration and refreshments
Welcome, opening remarks and housekeeping announcement
First session - Chairman: John Skidmore, University of Cambridge
Development of dual IGF1R/INSR inhibitors for oncology - a case study Sarah Major, Evotec
Computer-aided design and validation of multi-target ligands against key proteins in neurodegenerative diseases Leen Kalash, Cambridge University of Cambridge
Using structure-based drug design to combat antimicrobial resistance and exploit new antimicrobial targets Ricky Cain, University of Warwick
Student flash presentations (prior to lunchtime poster competition) 22 presentations each of two minutes - the listing may be found here
Lunch and poster session
Second session - Chairman: to be confirmed
Mining kinase signaling pathways for drug discovery opportunities Youcef Mehellou, Cardiff University
The design and synthesis of bromodomain photoaffinity probes David Fallon, University of Strathclyde
A droplet microfluidics platform for generating and screening cyclic peptide libraries of over a hundred million members Catrin Sohrabi, University of Southampton
Design and development of novel acetogenin-inspired trypanosomatid inhibitors Marija Zacharova, University of St Andrews
Third session - Chairman: Dave Alker, David Alker Associates
Structure based design of high affinity macrocyclic inhibitors of B-cell lymphoma 6 (BCL6) William McCoull, AstraZeneca
Aromatic ynamines: a new bio-orthogonal group for step-efficient sequential bio-conjugation Marine Hatit, University of Strathclyde
Towards selective FGFR kinase inhibitors: a de novo design approach Lewis Turner, University of Leeds
Cyclic peptide inhibition of epigenetic reader domains Oliver Coleman, University of Oxford
Presentation of prizes
Those who were interested in presenting relevant PhD or post-doctoral work were asked to submit a half-page abstract by Friday, 15th September in addition to registering. Those selected by the BMCS committee to give oral presentations were notified before 3rd November.
Travel expenses will be reimbursed to speakers.
This event is FREE, but all attendees were required to register as soon as possible and no later than by Friday, 1st December.